Augmentation of post-swelling surgical sealant potential of adhesive hydrogels by Shazly, Tarek M. et al.
Augmentation of post-swelling surgical sealant potential of
adhesive hydrogels
Tarek M. Shazlya,*, Aaron B. Bakera, John R. Naberb, Adriana Bona, Krystyn J. Van Vlietc,
and Elazer R. Edelmana,d
aHarvard–MIT Division of Health Sciences and Technology, Massachusetts Institute of
Technology, Cambridge, Massachusetts 02139
bDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts
02139
cDepartment of Materials Science and Engineering, Massachusetts Institute of Technology,
Cambridge, Massachusetts 02139
dCardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard
Medical School, Boston, Massachusetts 02115
Abstract
Two-component hydrogels formed with star polyethylene glycol amine and linear dextran
aldehyde polymers (PEG:dextran) show promise as tissue-specific surgical sealants. There is
however a significant loss of adhesion strength to soft tissues following PEG:dextran swelling,
which may limit material ability to appose disjoined tissues and prevent leakage from surgical
sites. We covalently incorporated the modified amino acid L-3,4-dihydroxyphenylalanine (L-
DOPA) into PEG:dextran to enhance post-swelling sealant performance. L-DOPA is an essential
component of marine animal adhesive plaques and has been used to confer wet adhesion in
synthetic materials. As both PEG:dextran cohesion and adhesion are mediated by aldehyde-amine
interactions, L-DOPA side-groups make it a potent network modulator with potential to affect
multiple material properties. Following one hour submersion in aqueous media, PEG:dextran
doped with 3 mM L-DOPA/M aldehyde on average swelled 50.3% less, had 287.4% greater
stiffness and had 53.6% greater functional adhesion strength compared to the neat hydrogel.
Increased concentrations of L-DOPA up to 11 mM L-DOPA/M aldehyde similarly curtailed
swelling and mitigated property loss with hydration, but sacrificed initial functional adhesion
strength, material modulus and biocompatibility. Taken together, these data support tailored L-
DOPA conjugation as a promising approach to enhance the clinical performance of PEG:dextran
sealants.
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1. Introduction
The bioadhesive properties of soft tissue sealants provide a range of potential therapeutic
benefits 1-3. Adhesive interactions between sealants and soft tissues are generally predicated
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on an in-situ material transformation, such as the hydroxide-catalyzed ionic polymerization
of cyanoacrylate derivatives or the calcium-mediated network assembly of fibrin glues 3,4.
Multiple determinants of sealant performance depend on material reactive chemistry and as
a result are challenging to optimize independently, including adhesion strength to target
tissue, degradation kinetics and the local biological response 2,5,6. A family of two-
component hydrogels composed of amine-functionalized star polyethylene glycol and
dextran aldehyde polymers (PEG:dextran) provides an aldehyde-mediated material system
with tunable adhesive and cohesive properties 7-11. PEG:dextran hydrogels are cohesively
crosslinked by imine bonds between amine and aldehyde groups mounted on high molecular
weight constituent polymers. An analogous chemistry controls the primary PEG:dextran
adhesive mechanism wherein free hydrogel aldehydes bind to tissue amines present on cells
or extracellular matrix. Rational adjustment of relative reactive group concentrations of
constituent polymers facilitates semi-independent regulation of adhesive and bulk material
properties in the PEG:dextran system, and can even do so on an application-specific basis
governed by the aldehyde-affinity of targeted soft tissues 7,10,11.
The characteristically high water content of swollen hydrogels traditionally imparts
excellent biocompatibility and has made them appealing candidates for biomaterial implants
12-14. Hydrogels are an attractive material class for sealant applications in particular, as their
mechanical properties after swelling are comparable to native soft tissue 15. Sustained
adhesion under physiologic loading implies that a severe mismatch in tissue-material
compliances will generate local stress concentrations at the adhesive interface and could
cause destruction of underlying tissue architecture and material failure 7,16. In addition to
having bulk mechanical properties in the range of soft tissues, PEG:dextran hydrogels
exhibit adjustable, viscoelastic adhesive interactions that confer failure resistance and
retention of tissue morphology in ex-vivo tissue-material constructs 7.
While hydrogel swelling is potentially beneficial to both sealant mechanics and
biocompatibility, bulk expansion will modulate multiple material properties and may reduce
sealant functionality. Here we observe that the adhesive interface between PEG:dextran and
duodenal tissue is physically altered and functionally compromised as a result of material
swelling. We adopt a biomimetic design strategy to mitigate swelling-induced functional
loss, specifically the conjugation of L-3,4-dihydroxyphenylalanine (L-DOPA) within the
PEG:dextran network. L-DOPA has been recognized as a key amino acid governing the
remarkable wet adhesion capabilities exhibited by marine animals, and has been
successfully used as a reactive element in other material systems under hydrated conditions
17-20. As both cohesion and adhesion of PEG:dextran are mediated by aldehyde-amine
interactions, the side groups of L-DOPA make it an ideal network modulator with potential
to affect multiple determinants of sealant performance. In this study, the effects of up to 11
mM L-DOPA/M aldehyde on PEG:dextran cohesive and functional adhesive properties
under hydrated conditions, as well as biocompatibility, are evaluated and related to surgical
sealant potential.
2. Materials and Methods
2.1 Material synthesis
The syntheses of star PEG amine and linear dextran aldehyde polymers along with their
copolymerization have been previously described 8,9. Briefly, eight-arm, 10 kDa star PEG
polymer with amine end groups was dissolved in purified water to form a 25 wt. % aqueous
solution with a pH of 8.5. Linear dextran (10 kDa) was oxidized with sodium periodate for 5
hours to produce dextran aldehyde polymer (50% oxidation of glucose rings, two aldehyde
groups per oxidized glucose ring). The dextran aldehyde polymer was dialyzed for 4 days,
lyophilized and reconstituted to form an 8.8 wt. % aqueous solution with a pH of 3.5.
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Polymeric constituents spontaneously react to form a two-component hydrogel
(PEG:dextran) following a volumetrically-balanced injection from a dual-chamber syringe
equipped with a 12-step mixing tip.
A fluorescein-labeled star PEG amine (FITC-PEG) polymer was synthesized to enable
fluorescent imaging of PEG:dextran. Star PEG amine (2.4 g) was dissolved in
dichloromethane (6 mL), followed by the addition of 15 mg of 6-(fluorescein-5-
carboxyamido) hexanoic acid, succinimidyl ester (Invitrogen) and 12 μL triethylamine
(Sigma). The solution was stirred continuously at room temperature for 48 hours. The
resulting solid after solvent evaporation was dissolved in 100 mL water, dialyzed against 4 L
of water (MWCO 500 membranes, Spectrum Labs) and lyophilized for 48 hours (-46°C,
3×10-3 mbar). FITC-PEG solutions of 25 wt. % solid content, 0.5% of which were
fluorescently labeled, were used for copolymerization with dextran aldehyde solutions.
A series of modified polymers was created by dissolving L-DOPA (Sigma) and lyophilized
dextran aldehyde in purified water for 3 hours at 60°C. After full dissolution and mixing,
homogeneous solutions were dialyzed for 24 hours against 4 L of water (as above).
Solutions were snap frozen in liquid nitrogen and lyophilized (as above). The solid was
recovered and reconstituted in water to yield L-DOPA-dextran aldehyde polymer solutions
with pH of 3.5. Both L-DOPA stock and L-DOPA-dextran aldehyde were stored under argon
until experimental use to prevent oxidation.
2.2 Material characterization: L -DOPA conjugation to dextran aldehyde
Hydrogen NMR was used to characterize L-DOPA conjugation to dextran aldehyde. A series
of homogeneous L-DOPA and dextran aldehyde solutions were prepared in D2O as described
above (without solution dialysis) with initial free L-DOPA concentrations of up to 12 wt. %.
Pure L-DOPA and dextran aldehyde solutions were also prepared for comparative analyses.
Selected solutions of L-DOPA and dextran aldehyde were analyzed immediately following
synthesis and after one week storage to verify conjugate stability. NMR spectra were
recorded (Bruker Avance 400 MHz instrument) and chemical shifts were reported in ppm
relative to the deuterated solvent.
2.3 Functional mechanical testing: ex-vivo burst pressure
Adult Sprague-Dawley rats (250 – 300 g, Charles River Laboratories, MA) were sacrificed
by carbon dioxide asphyxiation. The duodenum was excised and immersed in 10 ml Krebs-
Henseleit buffer at room temperature. Longitudinal duodenal segments were cut and inserted
into a mechanical testing apparatus capable of imparting controlled luminal flow (Bose®
Biodynamic Test Instrument, MN). A full-thickness wound was introduced by puncturing of
the intestinal wall with an 18 gauge needle. Wounds were then repaired with 200 μl
application of sealant to the serosal surface. A five minute sealant curing time was allowed,
after which intestinal samples were submerged in phosphate buffered saline (PBS) for up to
one hour. The burst pressure of repaired intestinal wounds was measured after
predetermined swelling times through gradual increase of lumen pressure developed through
restriction of flow (50 ml/min) distal to the sample lumen. Failure of the wound repair site
resulted in an immediate loss of luminal pressure and visible PBS leakage at the tissue-
material interface. The maximum luminal pressure prior to interface failure indicates the
wound burst pressure 7. All experiments involving animals were approved by the university
IACUC protocol and compliant with NIH guidelines for animal care.
2.4 Bulk material properties: swelling ratio and compressive modulus
The dynamic swelling ratio and bulk compressive modulus of modified PEG:dextran
hydrogels were examined as a function of swelling time in PBS. Pilot studies were
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conducted comparing PEG:dextran swelling in PBS versus aqueous albumin solutions of
varying concentration. No significant difference in material swelling behavior was observed
over 24 hours in solutions with albumin concentrations ranging from 0 to 5 wt. % (data not
shown). As the introduction of proteins into our assays could potentially confound
experimental results through tissue-protein interactions, all swelling experiments are
performed in PBS.
To measure both PEG:dextran swelling ratio and compressive modulus, cylindrical samples
(8 mm diameter, 4 mm height) were prepared with a silicon mold and analyzed after 0, 15,
30, or 60 minutes submersion in 50 mL PBS at room temperature. The dynamic swelling
ratio, qd(t), represents the percent increase in hydrogel weight as a function of swelling time,
t, and was calculated from the initial hydrogel weight, w(0), and the post-swelling weight,
w(t), as below:
The compressive elastic modulus (Ec) of swollen materials was measured using a
mechanical testing system featuring a low force load frame and a hydration chamber (Bose®
Biodynamic Test Instrument, MN). The use of a compressive as opposed to tensile testing
mode minimized experimental errors that are particularly problematic for swollen hydrogels
in hydrated environments, including grip-sample slippage or evolution of stress
concentration at the grip-sample interface. Cylindrical material samples were hydrated for
various times in 50 mL PBS and then subjected to a ramped compressive displacement
(displacement rate of 0.01 mm/sec, maximum displacement of 0.5 mm) while maintained in
PBS at room temperature. Sample load and displacement were continuously recorded at a
data acquisition rate of 100 points/sec. Acquired mechanical data were transformed to obtain
true stress versus strain curves based on swollen sample dimensions. For all materials,
stress-strain responses were linear under the described testing conditions and facilitated
calculation of Ec via linear regression of the stress-strain response.
2.5 Interfacial material density
An indirect metric of PEG:dextran network density forming the adhesive interface between
excised rat duodenal tissue and the material bulk was assessed throughout sample hydration
treatments in PBS of up to one hour. Material formulations (200 μl) featuring FITC-PEG
amine were applied to the serosal surface and allowed to polymerize for five minutes prior
to sample hydration. Following submersion in 50 mL PBS at room temperature for
designated swelling times, samples were snap frozen in liquid nitrogen, cryosectioned (20
μm thick sections) and mounted with DAPI-containing mounting medium (Vector Labs).
Fluorescent microscopy (Leica) and image analyses software (MetaMorph) were used to
depict the interfacial region between PEG:dextran and duodenal tissue. The linescan
software feature was used to quantify the fluorescent signal from FITC-PEG amine in the
interfacial regime, which was defined as the first 500 μm of material extending normally
from the serosal surface. The average fluorescent signal was calculated from 3-5 linescans
per image to reflect the PEG:dextran density comprising the adhesive interface.
2.6 Biocompatibility: in-vivo tissue response
The biocompatibility of PEG:dextran adhesives were evaluated by the local tissue response
to subcutaneous implants in mice. Briefly, a pocket was created in the dorsal subcutaneous
space of anesthetized C57BL/6 mice and 200 μl of material was injected into the pocket
using a syringe with a sterilized mixing tip. After nine days the skin and subcutaneous
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tissues at the implantation site were harvested. Tissue samples were frozen in liquid nitrogen
and stored at -80°C until histological analyses.
Harvested tissues were cryosectioned into 20 μm sections and stained with hematoxylin and
eosin using standard methods. Light microscopy was used to assess the local fibrotic
response in three randomly selected locations on each tissue section and quantified by the
total fibrotic layer thickness (Adobe Photoshop). Zymography was performed using
quenched fluorescein-labeled gelatin and fluorescence intensity was quantified and
normalized to indicate relative enzymatic activity local to each implanted material
(MetaMorph) 21. Immunohistochemical staining for macrophages was performed as
previously described 22. Briefly, sections were blocked in 10% goat serum for 40 minutes
and incubated overnight with a primary antibody for Mac-3 (Biolegend). The samples were
then washed three times with PBS and incubated with an anti-rat antibody labeled with
alexafluor-594 dye (Invitrogen). After two hours of incubation, the samples were washed
extensively and coverslipped in DAPI-containing mounting media (Vector Labs). The
fluorescent intensity from alexafluor-594 dye was quantified and normalized to provide a
metric of macrophage density at the implantation site.
2.7 Statistical analyses
Analysis of variance (ANOVA) with post-hoc analysis was used to compare sample means,
with a resultant p < 0.05 taken as statistically significant. Linear regressions between data
sets were also performed, for which Pearson’s correlation coefficient (R) and associated p-
value of the regression have been reported. Here again, p < 0.05 is considered statistically
significant.
3. Results
3.1 Material characterization
Hydrogen NMR was used to capture the signature spectra of dextran aldehyde (Fig. 1A), L-
DOPA (Fig. 1B) and a series of L-DOPA-dextran aldehyde conjugates. A diagnostic signal
for the imine proton present in the conjugate form (8.3 ppm) was integrated against the three
aromatic protons of L-DOPA (6.6 to 6.9 ppm) to determine the extent and stability of
conjugation 23. In a system exhibiting complete L-DOPA conjugation, a ratio of 3:1 between
the integrals of the aromatic L-DOPA and imine bond peaks would be expected and was
found (Fig. 1C), with conjugation stability verified following one week of solution storage.
Conversely, when conjugation is not complete and L-DOPA exists in both free and
conjugated forms, the integrals of the imine and aromatic peaks reflect the relative amount
of conjugation in the material system. Other chemical interactions within our material
system are possible, including hemiacetal linkages and L-DOPA self polymerization, and
may contribute to L-DOPA incorporation within PEG:dextran. Imine bond formation was
selected as the diagnostic signal for material characterization due to the emergence of the
expected and nearly exact 3:1 integral ratio at low L-DOPA concentrations (< 1 wt. % L-
DOPA) and the continuity this metric observed throughout the employed concentration
range.
The reaction efficiency nonlinearly decreased with initial L-DOPA concentration ranging
from 0.1 to 12 wt. %, with only 10.3 % conjugation achieved in the most concentrated
solution (Fig. 1D). Four L-DOPA-dextran aldehyde conjugates with initial L-DOPA
concentrations ranging from 0 to 6 wt. % were synthesized for further study. The molar
ratios of L-DOPA to aldehyde groups span 0 to 11 mM L-DOPA/M aldehyde and are used to
denote material composition in the remainder of this work (Table 1).
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3.2 Effect of hydration on adhesive closure of intestinal puncture wounds
The ex-vivo burst pressure of repaired puncture wounds following interfacial hydration
signifies the potential of adhesive sealants to mitigate tissue dehiscence or leakage in
multiple clinical scenarios. Intestinal samples were wounded, repaired with PEG:dextran
sealants and fully submerged in PBS for up to one hour prior to failure testing. The failure
resistance of wounds repaired with unmodified PEG:dextran monotonically decreased with
swelling time and exhibited a 39 ± 18% reduction in burst pressure following one hour (Fig.
2A). The effect of swelling time on L-DOPA-PEG:dextran was markedly different than the
neat hydrogel, as the burst pressure of the 3 mM conjugate only varied between 66 ± 6.7 and
77 ± 9.7 mmHg with no discernable trend over the observation time. Higher L-DOPA
concentrations also stabilized wound burst pressure throughout hydration, although the
diminished initial performance of 8 and 11 mM conjugates compared to unmodified
PEG:dextran indicates a loss of functional sealant potential with excessive doping.
3.3 Material response to hydration: dynamic swelling and compressive modulus
The dynamic swelling ratio (qd) and compressive modulus (Ec) of PEG:dextran sealants
were monitored throughout material sample hydration in PBS. Unmodified PEG:dextran
exhibited the greatest swelling, with a qd of 34.9 ± 1.5% after one hour of hydration, while
conjugate qd was approximately half that value for all tested L-DOPA concentrations (Fig.
2B). After 24 hours, the qd for unmodified PEG:dextran was 53.2 ± 4.9%, while conjugate
qd was comparatively lower and ranged from 27.4 ± 3.5% to 32.9 ± 3.8% (data not shown).
All materials exhibited a reduction in Ec after one hour swelling time (Fig. 2C), with a
significantly greater loss of stiffness in the unmodified PEG:dextran (86.2 ± 4.1% reduction
in Ec) as compared to L-DOPA conjugates (maximum Ec reduction of 44.8 ± 3.2% in the 11
mM conjugate). As with swelling, initial trends in modulus were retained over 24 hours,
where unmodified PEG:dextran exhibited an Ec of 28.3 ± 3.7 kPa and the conjugate family
had significantly higher Ec that ranged from 94 ± 8.6 kPa to 103 ± 10.9 kPa (data not
shown). Although material variants exhibited similar Ec at early swelling times (15 – 30
minutes), the loss of Ec relative to the pre-swelling value was always greatest for the
unmodified PEG:dextran; this trend reflects the differential effect of swelling. L-DOPA
conjugation appreciably curtailed both material swelling and concurrent decrease in elastic
modulus over the one hour hydration treatment, with minimal variation of either
phenomenon in the examined concentration range of 3 to 11 mM L-DOPA/M aldehyde.
3.4 Effect of L-DOPA on interfacial material density
Material density at adhesive interfaces between PEG:dextran variants and excised duodenal
tissue was assessed as a function of swelling time. The differential interfacial hydration
responses of unmodified PEG:dextran and the 3 mM conjugate are visually evident (Fig.
3A), with quantification of interfacial regime fluorescence suggesting both a swelling-
induced loss of PEG:dextran network density and the significant mitigation of this loss with
L-DOPA incorporation (Fig. 3B). A negative correlation between measured interfacial
density and material qd throughout hydration was expected and verified, as the reduction in
bulk density with increased swelling is reflected in the material morphology forming the
adhesive interface (Fig. 3C). Following one hour swelling treatments, interfacial material
density correlates well with the burst pressure of repaired wounds across the L-DOPA-
PEG:dextran variants, highlighting the influence of interfacial material properties on sealant
performance (Fig. 3D).
3.5 Pre- and post-swelling correlates to burst pressure
The pre-swelling burst pressures of duodenal wounds repaired with modified PEG:dextran
monotonically decreased with L-DOPA content, as the most concentrated conjugate failed at
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a lumen pressure of 47.1 ± 6.6 mmHg compared to 81.4 ± 5.6 mmHg for the unmodified
material (Fig. 2A, 0 min swelling time). Correlation of pre-swelling burst pressure and Ec
extended across the material series, and may reflect the common dependence of adhesive
and cohesive bond formation on aldehyde-amine crosslinking – both events are
compromised with L-DOPA conjugation to the dextran aldehyde constituent prior to network
formation (Fig. 4A). While the pre-swelling performance of PEG:dextran variants can be
understood in these terms, no direct relationship between burst pressure and Ec persisted
throughout material swelling. However, the total change of burst pressure after one-hour
hydration correlated strongly with the total extent of material swelling (Fig. 4B) and the
concomitant reduction of Ec (Fig. 4C). These correlations suggest that initial sealant
potential is diminished by swelling, and that L-DOPA simultaneously curtails swelling and
abrogates functional loss in PEG:dextran.
3.6 Effect of L-DOPA on material biocompatibility
The efficacy of strongly adherent surgical sealants is often limited by the associated tissue
response. PEG:dextran sealant biocompatibility was examined through subcutaneous
material implantations in mice. Three indicators of local tissue inflammation were assessed
based on microscopic analyses of stained sections, including the fibrotic layer thickness,
enzymatic activity and macrophage presence. PEG:dextran implants elicited a fibrotic
response to an extent dependent on L-DOPA content (Fig. 5A). The fibrous layer thickness
incited by unmodified PEG:dextran implantations was minimal (90 ± 40 μm), while 3 and 8
mM conjugates caused slightly increased thicknesses of 280 ± 40 μm and 190 ± 60 μm,
respectively. The tissue response to 11 mM implants was an order of magnitude more severe
than to unmodified PEG:dextran (fibrotic thickness of 890 ± 70 μm), suggesting that
hydrogel biocompatibility is compromised by excessive L-DOPA conjugation (Fig. 5B).
Excessive inflammatory cell-mediated proteolysis impedes wound repair via matrix
metalloprotease (MMP) cleavage of extracellular matrix proteins. MMP activity is often
elevated during surgery and particularly problematic at surgical anastomoses because of the
potential to destabilize wound sites and facilitate tissue dehiscence 24,25. The gelatinase
activity in local tissues following PEG:dextran implantations were measured using in-situ
zymography (Fig. 6A). The fluorescent intensity indicative of gelatinase activity
monotonically rose with L-DOPA content, suggesting an increased stimulation of pro-
inflammatory mediators and polymorphonuclear leukocytes (Fig. 6B).
Macrophages migrate to implantation sites and serve numerous functions associated with
tissue inflammation, including the regulation of fibroblast activity, secretion of MMPs and
phagocytosis of material debris 26,27. Fluorescent mac-3 labeling demonstrated that
macrophages were present at various densities following the implantation of PEG:dextran
materials (Fig. 7A). The density of macrophages in local tissues was low and statistically
indistinguishable until the highest L-DOPA concentration was used (Fig. 7B). Macrophage
density was approximately six-fold greater in tissues subjected to 11 mM L-DOPA/M
aldehyde implantations compared to unmodified PEG:dextran, which again suggests that
excessive L-DOPA content will substantially reduce material biocompatibility.
4. Discussion
Soft tissue sealant efficacy depends on the local environment following implantation, with a
range of tissue chemistries, surface morphologies, pH and mechanical forces encountered in
routine use 6. Common among all biological sealant applications is the eventual exposure of
material to physiological fluids. We posited that the adhesive interactions between soft
tissues and hydrogel-based sealants would be altered significantly by material swelling in a
manner that limits efficacy. In the present study, the reduction of PEG:dextran density at the
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adhesive interface is measured throughout initial material swelling and correlated to the
concomitant loss of sealant function ex-vivo. Although hydrogels are a biocompatible
material class for sealant development, these data suggest that their high characteristic
swelling may limit sealant function, motivating the pursuit for techniques of post-swelling
hydrogel property enhancement.
Nature often inspires engineering solutions to dilemmas of biomaterial design. In this work
we adopted a biomimetic approach to bulk PEG:dextran modification that was previously
used in other material systems. Multiple variants of the adhesive foot protein 3 in Mytilus
californianus (Mcfp-3) have been implicated in marine mussel adhesion, with all proteins
containing L-DOPA-rich domains 28. Reports on both surface- and bulk-incorporated L-
DOPA have collectively demonstrated modulated interactions with both organic and
inorganic surfaces and within material networks 19,29-31. Prior studies have found that L-
DOPA films can be applied to materials through simple dip-coating and promote adherence
to surfaces of metals, ceramics, polymers and various cell lines 31. The presently examined
L-DOPA conjugation to dextran aldehyde further recapitulates mussel adhesive plaques in
which adhesive proteins are embedded within polysaccharide matrices to facilitate flexibility
and failure resistance at the point of contact with underlying substrates 32.
The addition of L-DOPA to the PEG:dextran system affects material cohesive and adhesive
properties in a complex manner. Network cohesion, as reflected by pre-swelling Ec, falls in
a concentration-dependent manner that suggests L-DOPA reduces crosslinking by competing
with polymer amines for network-forming aldehydes. The increased size of the side group
raises the potential for steric inhibition of crosslinking, further affecting cohesion. In an
analogous manner pre-swelling burst pressure falls with L-DOPA conjugation, as
PEG:dextran aldehyde-mediated adhesion to soft tissue is observably compromised with the
reduction in material free aldehyde density 7,11.
Interestingly, pre-swelling correlation between Ec and burst pressure of repaired wounds
was observed, despite the different nature of these properties. This correlation is again
reflective of aldehyde group mediation of both the internal material crosslinking (with
constitutive PEG amine groups) and the external adhesive tissue crosslinking (with tissue-
present amine groups). However, correlation did not persist throughout the swelling period
of observation. With time, all material variants exhibited greater percent decrease in Ec as
compared to the measured decrease in burst pressure. We posit that differential trends
throughout swelling arise because distinct phenomena mediate bulk and adhesive properties.
Compressive testing of elastic moduli only probes the response of the bulk material, while
burst pressure reflects a combination of bulk and adhesive interfacial responses and
ultimately resistance to interfacial failure. These data suggest that burst pressure, which is
heavily influenced by tissue-material interfacial bond density, varies significantly with
material chemistry but is comparatively insensitive to swelling time. Conversely, Ec is
governed primarily by entropic as opposed to energetic resistance at low strains in
hydrogels, and thus varies markedly with swelling presumably due to concomitant network
chain reconfiguration 33.
Despite the apparent interference with aldehyde-mediated crosslinking, our study found that
3 mM L-DOPA/M aldehyde within PEG:dextran was minimally disruptive to initial sealant
potential and promoted retention of material stiffness, interfacial morphology and burst
pressure throughout hydration, ultimately conferring enhanced post-swelling function.
PEG:dextran properties, specifically those relevant to sealant applications, are presumably
stabilized by both the reduction in material swelling and L-DOPA-mediated bonding, which
could include internal interactions with self and external interactions with the tissue surface
34,35.
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We chose to characterize the biocompatibility of PEG:dextran conjugates in an animal
model that is not reflective of a specific clinical scenario. Given the multitude of potential
applications of surgical sealants, a general assay of biocompatibility such as represented by
a subcutaneous implantation model should precede more specific animal models. Moreover,
the subcutaneous model allows one to divorce the functional efficacy of a particular material
formulation from the base biocompatibility, while more complex models would instead
reflect a combination of sealant performance, biocompatibility and functional effects in a
specific clinical application.
Macrophage localization represents a metric of particular interest due to the pivotal role
these cells play in the tissue response to implanted materials, including inflammatory
mediation and formation of a fibrous capsule. Macrophages complex with fibronectin
through cell surface integrin receptors, leading to various intracellular signaling events and
the eventual upregulation of inflammatory cytokines 36. Macrophages are crucial mediators
in the immune response, as they ensure phagocytosis of foreign debris, release biologically
active compounds and present antigens to immunecompetent cells. Thus, macrophage
activation may influence nearly every aspect of both normal and abnormal immune and
inflammatory responsiveness, and is of paramount importance in assessing general
biocompatibility. 37
Although 3 mM L-DOPA/M aldehyde had only a minor effect of tissue response, multiple
tissue response metrics indicated that PEG:dextran biocompatibility was significantly
reduced following implantation of 11 mM L-DOPA/M aldehyde conjugate. The reduction in
biocompatibility at high doping levels can be readily attributed to two potential sources: L-
DOPA itself or the aldehyde groups liberated by the aforementioned disruption of
PEG:dextran network formation. The latter of these possibilities is supported by previous
work, which showed a reduction in PEG:dextran biocompatibility with increasing free
aldehyde content 10. Irrespective of the underlying cause, trends in both the local tissue
response and burst pressure data provide incentive to carefully adjust L-DOPA concentration
within PEG:dextran as a means to enhance post-swelling sealant performance.
A limitation of this work is the swelling times over which material behavior was assessed.
We were only able to analyze sealant function for one hour after swelling given the need to
preserve tissue integrity. At these short times, the hydrogels do not reach equilibrium
swelling states. Moreover, other dynamic processes, which occur over longer times, such as
hydrolytic bond degradation and wound healing, are not considered here, yet will
undoubtedly influence interfacial failure resistance. Long term sealant behavior can however
be extrapolated from the presented data set, as we would predict that materials which
ultimately swell less would better maintain their maximal functional potential.
Biomaterials must be evaluated at physiologically-relevant states to understand their true
clinical potential. Hydrogels are appealing platforms for development of implants that
interact intimately with soft tissues because of their composition and associated
biocompatibility; yet high material swelling can strongly influence adhesive interactions.
The present study demonstrates that low concentrations of L-DOPA within PEG:dextran can
effectively combat functional loss related to swelling. Moreover, when viewed in concert
with previous studies on PEG:dextran, this work adds to the collection of general strategies
for improving sealant functionality, namely maintaining tissue viscoelasticity after adhesion,
considering tissue-specific biochemistry for targeted adhesion and now limiting material
swelling in-situ 7,10. The results of this work provide a general impetus to regulate material
swelling in order to promote the retention of functional tissue-material adhesive interactions,
and as such may be relevant to other hydrogel-based adhesive systems.
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5. Conclusion
It is recognized that the local physiological environment can modulate biomaterial implants
in a variety of ways and often to an extent which diminishes their therapeutic potential. In-
situ swelling of a hydrogel-based soft tissue sealant represents a biologically-induced
dynamic which may reduce therapeutic potential in applications involving substantial
physiological loads. We demonstrate that PEG:dextran sealants undergo a swelling-induced
reduction of material density at the adhesive interface and suffer a correlated loss of function
in an ex-vivo model. Conjugation of L-DOPA to PEG:dextran limits material swelling and
enhances hydrated sealant performance. Functionally effective doping levels of 3 mM L-
DOPA/M aldehyde within PEG:dextran did not substantially alter biocompatibility as
indicated by the subcutaneous tissue response to material implants. In general, L-DOPA-
based modification provides a means to safely enhance post-swelling adhesive properties
and as such is a promising approach to advance surgical sealant design.
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Figure 1.
(A) NMR spectra of dextran aldehyde, (B) L-DOPA, and (C) a 0.3 wt % conjugation of L-
DOPA to dextran aldehyde. Following conjugation, the triplet peaks (6.6–6.9 ppm) indicate
total L-DOPA content, whereas the imine peak (8.3 ppm) was diagnostic of conjugated L-
DOPA. The ratio between the integrals of the triplet and imine peaks was used to calculate
the extent of conjugation following reaction, with a 3:1 ratio indicating complete
conjugation. (D) The % of initial L-DOPA (▲) and the molar ratio of L-DOPA to
constituent aldehyde groups (■) conjugated after reaction are presented as a function of
initial L-DOPA concentration to indicate the variation of reaction efficiency and product
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Figure 2.
(A) The ex vivo burst pressure of repaired rat duodenal wounds was assessed after various
swelling times. Puncture wounds were repaired with PEG:dextran formulations featuring L-
DOPA at molar concentrations of 0 (◆), 3 (■), 8 (▲), or 11 (x) mM L-DOPA/M aldehyde.
After sample treatment for the designated swelling time, sample lumens were perfused with
PBS (50 mL/min) and gradually pressurized. The pressure at which the wound repair site
mechanically failed was recorded as the burst pressure. (B) The dynamic swelling ratio, qd,
and the (C) compressive elastic modulus, Ec, of the same materials were also assessed as
function of swelling time. Error bars in all graphs represent 1 standard error of measurement
(n = 3 to 5). * indicates p < 0.05 determined by ANOVA with post hoc analysis when
compared with 60-min swelling time for unmodified PEG:dextran
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Figure 3.
(A) The density of material forming the adhesive interface between excised duodenal tissue
(cell nuclei stained blue with DAPI) and material bulk (FITC-labeled PEG:dextran variants
appear green) varied with swelling time. The interfacial material density of unmodified
PEG: dextran (upper panels) visibly diminished with swelling time, whereas the interfacial
density of the 3 mM L-DOPA/M aldehyde variant (bottom panels) remained comparatively
stable. Scale bar = 1000 μm and applies to all images. (B) The relative density of material
extending normally from the tissue surface (500 μm) was assessed with analytical
microscopy and presented at select swelling times for unmodified PEG:dextran and the 3
mM L-DOPA/M aldehyde conjugate. Error bars represent 1 standard error of measurement
(n = 4). * indicates p < 0.05 determined by ANOVA with post hoc analysis when compared
to 0-min swelling time for each material. (C) The dynamic swelling ratio, qd, inversely
correlates (R = −0.96, p < 0.05, solid line represents linear fit of data) to the interfacial
densities in the above images (A), supporting the intuitive loss of material density with
swelling at the adhesive interface. (D) Linear correlation (R = 0.92, p < 0.05, solid line
represents linear fit of data) exists between sample burst pressure and interfacial density
across all material samples after 1-h hydration. Data point labels (C and D) reflect material
conjugation level (mM L-DOPA/M aldehyde)
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Figure 4.
(A) Before material hydration, positive correlation (R = 0.96, p < 0.05) exists between the
material compressive modulus, Ec, and the wound burst pressure when repaired with the
corresponding PEG:dextran formulation. (B) After a full hour of hydration, the extent to
which initial burst pressure changed from the preswell value negatively correlated (R =
−0.99, p < 0.05) to material swelling ratio, qd, and (C) positively correlated (R = 0.98, p <
0.05) to the change in material modulus. Error bars represent 1 standard error of
measurement in all graphs (n = 3 to 5)
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Figure 5.
(A) Tissue fibrous layer thickness local to PEG:dextran variants increases with L-DOPA
content. Mice were implanted with material (200 μL) subcutaneously and tissues were
harvested after 9 days. Hematoxylin and eosin stained sections of tissue demonstrate
increased cellular infiltration and formation of fibrous tissue surrounding the implanted
material. Scale bar = 500 μm and applies to all images. (B) Fibrous layer thickness was
measured and found to be significantly increased in 11 mM L-DOPA/M aldehyde conjugate.
Error bars represent 1 standard error of measurement (n = 4 to 5). * indicates p < 0.05
determined by ANOVA with post hoc analysis when compared to unmodified PEG:dextran
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Figure 6.
(A) Analysis of gelatinase activity in subcutaneous tissue following implantation of
PEG:dextran variants. In situ zymography with an internally quenched FITC-labeled gelatin
substrate indicated gelatinase activity. Scale bar = 1000 μm and applies to all images. (B) L-
DOPA conjugation within PEG:dextran stimulated local tissue gelatinase activity as
indicated by a monotonic rise of relative fluorescent measurements with increasing L-DOPA
concentration. Error bars represent 1 standard error of measurement (n = 4 to 5). * indicates
p < 0.05 determined by ANOVA with post hoc analysis when compared with unmodified
PEG:dextran
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Figure 7.
(A) Macrophage infiltration (red by immunofluorescent staining for Mac-3, cell nuclei
stained blue with DAPI) varied among subcutaneous implantations of PEG:dextran
materials. Scale bar = 1000 μm and applies to all images. (B) Macrophage infiltration was
quantified with analytical microscopy and found to be increased in 11 mM L-DOPA/M
aldehyde content material. Error bars represent 1 standard error of measurement (n = 4 to 5).
* indicates p < 0.05 determined by ANOVA with post hoc analysis when compared with
unmodified PEG:dextran.
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